Stocktoria
CollPlant Biotechnologies Ltd CLGN
Nasdaq · stock · Orthopedic, Prosthetic & Surgical Appliances & Supplies · website · IPO 1993-09-01
CollPlant Biotechnologies Ltd financials (annual)
Bars are annual figures from 2019 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Revenue | $2.4M | $515,000 | $11.0M | $299,000 | $15.6M | $6.1M | $2.3M |
| Gross profit | $1.5M | -$1.1M | $9.0M | -$101,000 | $13.6M | $3.1M | $439,000 |
| R&D expense | $8.2M | $10.5M | $10.5M | $10.3M | $7.6M | $4.1M | $4.4M |
| Operating income | -$11.5M | -$17.3M | -$7.5M | -$17.1M | $65,000 | -$5.6M | -$7.6M |
| Income tax | — | $46.0M | $60.0M | — | — | — | — |
| Net income | -$11.5M | -$16.6M | -$7.0M | -$16.9M | $237,000 | -$5.8M | -$11.2M |
| EPS (diluted) | $-0.94 | $-1.45 | $-0.62 | $-1.53 | $0.02 | $-0.84 | $-2.23 |
| Operating cash flow | -$9.4M | -$14.1M | -$2.8M | -$13.7M | $2.5M | -$4.5M | -$5.7M |
| Free cash flow | -$9.4M | -$14.6M | -$3.7M | -$15.0M | $1.1M | -$4.9M | -$7.2M |
| Cash & equivalents | $5.6M | $11.9M | $26.7M | $29.7M | $13.1M | $3.3M | $3.8M |
| Inventory | $573,000 | $440,000 | $714,000 | $1.4M | $1.1M | $1.3M | $888,000 |
| Total assets | $10.8M | $18.7M | $34.1M | $37.8M | $51.2M | $10.8M | $10.8M |
| Total liabilities | $4.7M | $5.2M | $5.8M | $5.5M | $6.1M | $6.4M | $6.7M |
| Shareholders' equity | $6.1M | $13.5M | $28.3M | $32.3M | $45.1M | $4.5M | $4.1M |
Growth · year-over-year · Revenue CAGR 0.4%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Revenue growth | +360.4% | -95.3% | +3565.2% | -98.1% | +154.9% | +164.8% | — |
| Net income growth | — | — | — | -7241.4% | — | — | — |
| EPS growth | — | — | — | -7750.0% | — | — | — |
| Free cash flow growth | — | — | — | -1495.3% | — | — | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.